Traitement - activities

Covid: Eli Lilly antibody therapy said to reduce hospitalization risks, a study finds

As the race for Covid vaccines and therapies is speeding up all over the world, drugmaker Eli Lilly announced this Wednesday March 10 their antibody therapy mixing Bamlanivimab and Etsesevimab is said to reduced by 87% hospitalization and death risk in the event of severe infection. A combined therapy that received emergency use authorization back to late February from the Food & Drug Administration.

Covid: WHO does not recommend hydroxychloroquine as a preventive drug against the disease

This Tuesday March 2, WHO announced in a memo released in the British Medical Journal that Hydroxychloroquine was not recommended as a preventive drug against Covid, relying on six randomized clinical trials, results have shown the inefficiency of the product to fight against severe coronavirus. In addition to those studies, a study carried out by Epi-phare, lead to the same conclusion.

Coronavirus: “Positive results” for the remdesivir/diltiazem treatment the Inserm says

Searchers from the French National Institute for Health and Medical Research (Inserm) in Lyon showed that mixing two medicines, remdesivir and diltiazem, gave “positive results” for a pre-clinical phase. A new step for the discovery of an effective treatment against coronavirus.

Coronavirus: the European Union allows putting Remdesivir on the market

Remdesivir is at the heart of research against coronavirus and has been adopted in the United-States in early May. The European Union is now validating the authorization to put the treatment on the market.

Coronavirus: WHO urges promising steroid Dexamethasone production to boom

Can dexamethasone be a cure to coronavirus? The clinical trial ran by British searchers seems promising, so much that the World Health Organization hailed the results the British scientists have found and urges to boom production.

Coronavirus: Anakinra, a promising treatment?

Is Anakinra an effective treatment against coronavirus? According to a French study released in The Lancet, the medicine usually prescribed for rheumatic diseases released encouraging results on severe Covid-19 forms. First results that will have to be confirmed on a greater number of patients.

Coronavirus: Macron meets with Raoult, scientist’ latest study results

French President Emmanuel Macron has met French infectious disease specialist and Professor of Microbiology Didier Raoult in Marseilles this Thursday April 9, 2020 in the afternoon. The meeting – that lasted 3 hours – was the opportunity for the controversial professor to present the results of his latest studies to the French President.